|
1
|
Bos JD: The skin as an organ of immunity.
Clin Exp Immunol. 107(suppl 1): 3–5. 1997.PubMed/NCBI
|
|
2
|
Bos JD: Skin immune system: Cutaneous
immunology and clinical immunodermatology. 3rd edition. CRC Press;
Boca Raton, FL: pp. 3–13. 2005
|
|
3
|
Neagu M: The immune system-a hidden
treasure for biomarker discovery in cutaneous melanoma. Advances in
Clinical chemistry. 58. Makowski GS: Academic Press; Burlington,
ON; pp. 89–140. 2012, View Article : Google Scholar
|
|
4
|
Elentner A, Ortner D, Clausen B, Gonzalez
FJ, Fernández-Salguero PM, Schmuth M and Dubrac S: Skin response to
a carcinogen involves the xenobiotic receptor pregnane X receptor.
Exp Dermatol. 24:835–840. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Vries E, Trakatelli M, Kalabalikis D,
Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D, Sotiriadis D,
Ioannides D, Aquilina S, Apap C, et al: EPIDERM Group: Known and
potential new risk factors for skin cancer in European populations:
A multicentre case-control study. Br J Dermatol. 167(Suppl 2):
1–13. 2012. View Article : Google Scholar
|
|
6
|
Diepgen TL and Mahler V: the epidemiology
of skin cancer. Br J Dermatol. 146(Suppl 61): 1–6. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ene CD, Anghel AE, Neagu M and Nicolae I:
25-OH Vitamin D and interleukin-8: Emerging biomarkers in cutaneous
melanoma development and progression. Mediators Inflamm.
2015:9048762015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Căruntu C, Grigore C, Căruntu A,
Diaconeasa A and Boda D: The role of stress in skin diseases.
Intern Med. 8:73–84. 2011.
|
|
9
|
Căruntu C, Ghiţă Ma, Căruntu A and Boda D:
the role of stress in the multifactorial etiopathogenesis of acne.
Ro Med J. 58:98–101. 2011.
|
|
10
|
Căruntu C, Boda D, Musat S, Căruntu A and
Mandache E: Stress-induced mast cell activation in glabrous and
hairy skin. Mediators Inflamm. 2014:1059502014. View Article : Google Scholar :
|
|
11
|
Caruntu C, Boda D, Constantin C, Caruntu A
and Neagu M: Catecholamines increase in vitro proliferation of
murine B16F10 melanoma cells. Acta Endocrinologica (Buc).
10:545–558. 2014. View Article : Google Scholar
|
|
12
|
Marks F and Fürstenberger G: Experimental
evidence that skin carcinogenesis is a multistep phenomenon. Br J
Dermatol. 115(suppl 31): 1–8. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bibby Mc: the specificity of early changes
in the skin during carcinogenesis. Br J Dermatol. 104:485–488.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Waterston RH, Lindblad-Toh K, Birney E,
Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R,
Alexandersson M, An P, et al: Mouse Genome Sequencing Consortium:
Initial sequencing and comparative analysis of the mouse genome.
Nature. 420:520–562. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mestas J and Hughes CC: Of mice and not
men: differences between mouse and human immunology. J Immunol.
172:2731–2738. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shepherd FA and Sridhar SS: Angiogenesis
inhibitors under study for the treatment of lung cancer. Lung
Cancer. 41(Suppl 1): S63–S72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oehler MK and Bicknell R: The promise of
anti-angiogenic cancer therapy. Br J Ccancer. 82:749–752. 2000.
View Article : Google Scholar
|
|
18
|
Panitch HS, Hirsch RL, Haley AS and
Johnson KP: Exacerbations of multiple sclerosis in patients treated
with gamma interferon. Lancet. 1:893–895. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sykes M: Mixed chimerism and transplant
tolerance. Immunity. 14:417–424. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wood KJ: Passenger leukocytes and
microchimerism: What role in tolerance induction? Transplantation.
75(suppl 9): 17s–20s. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monaco AP: chimerism in organ
transplantation: conflicting experiments and clinical observations.
Transplantation. 75(suppl 9): 13s–16s. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Elbe A, Foster CA and Stingl G: T-cell
receptor alpha beta and gamma delta T cells in rat and human skin -
are they equivalent? Semin Immunol. 8:341–349. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gardner RV, Velez MC, Ode DL, Lee JW and
Correa H: Gamma/delta T-cell lymphoma as a recurrent complication
after transplantation. Leuk Lymphoma. 45:2355–2359. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bergstresser PR, Tigelaar RE, Dees JH and
Streilein JW: Thy-1 antigen-bearing dendritic cells populate murine
epidermis. J Invest Dermatol. 81:286–288. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jameson J and Havran WL: Skin gammadelta
T-cell functions in homeostasis and wound healing. Immunol Rev.
215:114–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Jong A, Peña-Cruz V, Cheng TY, Clark
RA, Van Rhijn I and Moody DB: CD1a-autoreactive T cells are a
normal component of the human αβ T cell repertoire. Nat Immunol.
11:1102–1109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lindlahr H: Nature Cure: Philosophy and
practice based on the unity of disease and cure. 20th edition.
Nature Cure Publishing company; Chicago, IL: 1922
|
|
28
|
Ward PA: Acute and chronic inflammation.
Fundamentals of Inflammation. Serhan CN, Ward PA and Gilroy DW:
Cambridge University Press; Cambridge: pp. 1–16. 2010, View Article : Google Scholar
|
|
29
|
Neagu M, Constantin C, Dumitrascu GR, Lupu
AR, Caruntu C, Boda D and Zurac S: Inflammation markers in
cutaneous melanoma - edgy biomarkers for prognosis. Discoveries.
3:e382015. View Article : Google Scholar
|
|
30
|
DeNardo DG and Coussens LM: Inflammation
and breast cancer. Balancing immune response: Crosstalk between
adaptive and innate immune cells during breast cancer progression.
Breast Cancer Res. 9(212)2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gonda TA, Tu S and Wang TC: chronic
inflammation, the tumor microenvironment and carcinogenesis. Cell
Cycle. 8:2005–2013. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nedoszytko B, Sokołowska-Wojdyło M,
Ruckemann-Dziurdzińska K, Roszkiewicz J and Nowicki RJ: Chemokines
and cytokines network in the pathogenesis of the inflammatory skin
diseases: Atopic dermatitis, psoriasis and skin mastocytosis.
Postepy Dermatol Alergol. 31:84–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Neagu M, Constantin C and Longo C:
Chemokines in the melanoma metastasis biomarkers portrait. J
Immunoassay Immunochem. 36:559–566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Justus CR, Leffler N, Ruiz-Echevarria M
and Yang LV: In vitro cell migration and invasion assays. J Vis
exp. View Article : Google Scholar : 2014.PubMed/NCBI
|
|
36
|
Bosanquet DC, Ye L, Harding KG and Jiang
WG: Expressed in high metastatic cells (Ehm2) is a positive
regulator of keratinocyte adhesion and motility: The implication
for wound healing. J Dermatol Sci. 71:115–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oser M, Yamaguchi H, Mader CC,
Bravo-Cordero JJ, Arias M, Chen X, Desmarais V, van Rheenen J,
koleske AJ and Condeelis J: Cortactin regulates cofilin and N-WASp
activities to control the stages of invadopodium assembly and
maturation. J Cell Biol. 186:571–587. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schäfer M and Werner S: Cancer as an
overhealing wound: An old hypothesis revisited. Nat Rev Mol Cell
Biol. 9:628–638. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kong D, Li Y, Wang Z and Sarkar FH: Cancer
stem cells and epithelial-to-mesenchymal transition
(EMT)-phenotypic cells: are they cousins or twins? Cancers (Basel).
3:716–729. 2011. View Article : Google Scholar
|
|
40
|
Plikus MV, Guerrero-Juarez CF, Treffeisen
E and Gay DL: Epigenetic control of skin and hair regeneration
after wounding. Exp Dermatol. 24:167–170. 2015. View Article : Google Scholar :
|
|
41
|
Yan C, Grimm WA, Garner WL, Qin L, Travis
T, Tan N and Han YP: Epithelial to mesenchymal transition in human
skin wound healing is induced by tumor necrosis factor-alpha
through bone morphogenic protein-2. Am J Pathol. 176:2247–2258.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leopold PL, Vincent J and Wang H: A
comparison of epithelial-to-mesenchymal transition and
re-epithelialization. Semin Cancer Biol. 22:471–483. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Graf T and Enver T: Forcing cells to
change lineages. Nature. 462:587–594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Brittan M, Braun KM, Reynolds LE, Conti
FJ, Reynolds AR, Poulsom R, Alison MR, Wright NA and Hodivala-Dilke
KM: Bone marrow cells engraft within the epidermis and proliferate
in vivo with no evidence of cell fusion. J Pathol. 205:1–13. 2005.
View Article : Google Scholar
|
|
45
|
Sasaki M, Abe R, Fujita Y, Ando S, Inokuma
D and Shimizu H: Mesenchymal stem cells are recruited into wounded
skin and contribute to wound repair by transdifferentiation into
multiple skin cell type. J Immunol. 180:2581–2587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Egeblad M, Nakasone ES and Werb Z: Tumors
as organs: Complex tissues that interface with the entire organism.
Dev Cell. 18:884–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dunham LJ: Cancer in man at site of prior
benign lesion of skin or mucous membrane: A review. Cancer Res.
32:1359–1374. 1972.PubMed/NCBI
|
|
48
|
Frei JV and Stephens P: the correlation of
promotion of tumour growth and of induction of hyperplasia in
epidermal two-stage carcinogenesis. Br J Cancer. 22:83–92. 1968.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kemp CJ: Multistep skin cancer in mice as
a model to study the evolution of cancer cells. Semin Cancer Biol.
15:460–473. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Verma AK, Wheeler DL, Aziz MH and
Manoharan H: Protein kinase Cepsilon and development of squamous
cell carcinoma, the nonmelanoma human skin cancer. Mol Carcinog.
45:381–388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rundhaug JE and Fischer SM: Tumor
promoters and models of promotion. comprehensive toxicology. 12.
Sipes IG, McQueen CA and Gandolfi AJ: Elsevier Sciences Ltd; New
York, NY: pp. 325–348. 1997
|
|
52
|
Abel EL, Angel JM, Kiguchi K and
DiGiovanni J: Multi-stage chemical carcinogenesis in mouse skin:
Fundamentals and applications. Nat Protoc. 4:1350–1362. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Digiovanni J: Modification of multistage
skin carcinogenesis in mice. Modification of tumor development in
rodents. 33. Ito N and Sugano H: Karger, Basel; pp. 192–229.
1991
|
|
54
|
Segrelles C, Lu J, Hammann B, Santos M,
Moral M, Cascallana JL, Lara MF, Rho O, Carbajal S, Traag J, et al:
Deregulated activity of Akt in epithelial basal cells induces
spontaneous tumors and heightened sensitivity to skin
carcinogenesis. Cancer Res. 67:10879–10888. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Amornphimoltham P, Leelahavanichkul K,
Molinolo A, Patel V and Gutkind JS: Inhibition of Mammalian target
of rapamycin by rapamycin causes the regression of
carcinogen-induced skin tumor lesions. Clin Cancer Res.
14:8094–8101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bassi DE and Klein-Szanto AJP: Current
protocols in pharmacology. Carcinogen-induced animal models of head
and neck squamous cell carcinoma. John Wiley & Sons, Inc;
Hoboken, NJ: pp. 14.12.11–14.12.19. 2007
|
|
57
|
Ashman LK, Murray AW, Cook MG and
Kotlarski I: Two-stage skin carcinogenesis in sensitive and
resistant mouse strains. Carcinogenesis. 3:99–102. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wolf CR and Henderson CJ: Use of
transgenic animals in understanding molecular mechanisms of
toxicity. J Pharm Pharmacol. 50:567–574. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sundberg JP, Sundberg BA and Beamer WG:
Comparison of chemical carcinogen skin tumor induction efficacy in
inbred, mutant, and hybrid strains of mice: Morphologic variations
of induced tumors and absence of a papillomavirus cocarcinogen. Mol
carcinog. 20:19–32. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
McCormick DL and Moon RC: Antipromotional
activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin
tumorigenesis in CD-1 and SENCAR mice. Cancer Lett. 31:133–138.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Warren BS and Slaga TJ: Mechanisms of
inhibition of tumor progression. Basic Life Sci. 61:279–289.
1993.PubMed/NCBI
|
|
62
|
Xu H, Cheepala S, McCauley E, Coombes K,
Xiao L, Fischer SM and Clifford JL: Chemoprevention of skin
carcinogenesis by phenylretinamides: retinoid receptor-independent
tumor suppression. Clin Cancer Res. 12(3 Pt 1): 969–979. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Miller SJ, Wei ZG, Wilson C, Dzubow L, Sun
TT and Lavker RM: Mouse skin is particularly susceptible to tumor
initiation during early anagen of the hair cycle: Possible
involvement of hair follicle stem cells. J Invest Dermatol.
101:591–594. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Marinescu B, Isvoranu G, Constantin C,
Coman C, Zurac S, Căruntu C, Boda D, Neagu M and Călin M:
Experimental model of chemically induced skin carcinogenesis in
mice. Rev Rom Med Vet. 20:97–104. 2010.
|
|
65
|
Home Office: Animals (Scientific
Procedures) Act 1986: Code of Practice for the Housing and Care of
Animals Used in Scientific Procedures. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/228831/0107.pdf.
accessed January 20, 2016.
|
|
66
|
Diaconeasa A, Boda D, Neagu M, Constantin
C, Căruntu C, Vlădău L and Guţu D: The role of confocal microscopy
in the dermato-oncology practice. J Med Life. 4:63–74.
2011.PubMed/NCBI
|
|
67
|
Căruntu C and Boda D: Evaluation through
in vivo reflectance confocal microscopy of the cutaneous neurogenic
inflammatory reaction induced by capsaicin in human subjects. J
Biomed Opt. 17(085003)2012. View Article : Google Scholar
|
|
68
|
Li Y, Gonzalez S, Terwey TH, Wolchok J, Li
Y, Aranda I, Toledo-Crow R and Halpern AC: Dual mode reflectance
and fluorescence confocal laser scanning microscopy for in vivo
imaging melanoma progression in murine skin. J Invest Dermatol.
125:798–804. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Li Z, Huang P, Zhang X, Lin J, Yang S, Liu
B, Gao F, Xi P, Ren Q and Cui D: RGD-conjugated dendrimer-modified
gold nanorods for in vivo tumor targeting and photothermal therapy.
Mol Pharm. 7:94–104. 2010. View Article : Google Scholar
|
|
70
|
Căruntu C, Boda D, Guţu De and Căruntu A:
In vivo reflectance confocal microscopy of basal cell carcinoma
with cystic degeneration. Rom J Morphol Embryol. 55:1437–1441.
2014.
|
|
71
|
Căruntu C, Boda D, Căruntu A, Rotaru M,
Baderca F and Zurac S: In vivo imaging techniques for psoriatic
lesions. Rom J Morphol Embryol. 55(Suppl 3): 1191–1196. 2014.
|
|
72
|
Croix CS, Zipfel WR and Watkins SC:
Potential solutions for confocal imaging of living animals.
Biotechniques. 43(Suppl 1): 14–19. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fujiki H, Sueoka E and Suganuma M: Tumor
promoters: From chemicals to inflammatory proteins. J Cancer Res
Clin Oncol. 139:1603–1614. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Neagu M, Constantin C, Martin D, Albulescu
L, Iacob N and Ighigeanu D: Whole body microwave irradiation for
improved dacarbazine therapeutical action in cutaneous melanoma
mouse model. Radiol Res Pract. 2013(414816)2013.
|
|
75
|
Schwarz M, Münzel PA and Braeuning A:
Non-melanoma skin cancer in mouse and man. Arch Toxicol.
87:783–798. 2013. View Article : Google Scholar
|
|
76
|
Prasad R and Katiyar SK: Ultraviolet
radiation-induced inflammation activates β-catenin signaling in
mouse skin and skin tumors. Int J Oncol. 44:1199–1206.
2014.PubMed/NCBI
|
|
77
|
Huang YF, Yeh HY and Soo VW: Inferring
drug-disease associations from integration of chemical, genomic and
phenotype data using network propagation. BMC Med Genomics. 6(Suppl
3): S42013. View Article : Google Scholar
|
|
78
|
Yang AY, Lee JH, Shu L, Zhang C, Su ZY, Lu
Y, Huang MT, Ramirez C, Pung D, Huang Y, et al: Genome-wide
analysis of DNA methylation in UVB- and DMBA/TPA-induced mouse skin
cancer models. Life Sci. 113:45–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Uekusa S, Kawashima H, Sugito K, Yoshizawa
S, Shinojima Y, Igarashi J, Ghosh S, Wang X, Fujiwara K, Ikeda T,
et al: Nr4a3, a possibile oncogenic factor for neuroblastoma
associated with CpGi methylation within the third exon. Int J
Oncol. 44:1669–1677. 2014.PubMed/NCBI
|
|
80
|
Saito M, Okumura K, Miura I, Wakana S,
Kominami R and Wakabayashi Y: Identification of Stmm3 locus
conferring resistance to late-stage chemically induced skin
papillomas on mouse chromosome 4 by congenic mapping and
allele-specific alteration analysis. Exp Anim. 63:339–348. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Okumura K, Saito M, Isogai E, Miura I,
Wakana S, Kominami R and Wakabayashi Y: Congenic mapping and
allele-specific alteration analysis of Stmm1 locus conferring
resistance to early-stage chemically induced skin papillomas. PLos
One. 9:e972012014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Han G, Lu SL, Li AG, He W, Corless CL,
Kulesz-Martin M and Wang XJ: Distinct mechanisms of
TGF-beta1-mediated epithelial-to-mesenchymal transition and
metastasis during skin carcinogenesis. J Clin Invest.
115:1714–1723. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Matsumoto T, Jiang J, Kiguchi K, Ruffino
L, Carbajal S, Beltrán L, Bol DK, Rosenberg MP and DiGiovanni J:
Targeted expression of c-Src in epidermal basal cells leads to
enhanced skin tumor promotion, malignant progression, and
metastasis. Cancer Res. 63:4819–4828. 2003.PubMed/NCBI
|
|
84
|
Chen J and Roop DR: Genetically engineered
mouse models for skin research: Taking the next step. J Dermatol
Sci. 52:1–12. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wilker E, Lu J, Rho O, Carbajal S, Beltrán
L and DiGiovanni J: Role of PI3K/Akt signaling in insulin-like
growth factor-1 (IGF-1) skin tumor promotion. Mol Carcinog.
44:137–145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer - a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar
|
|
88
|
Syed DN, Khan MI, Shabbir M and Mukhtar H:
MicroRNAs in skin response to UV radiation. Curr Drug Targets.
14:1128–1134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Singh A, Willems E, Singh A, Hafeez BB,
Ong IM, Mehta SL and Verma AK: Ultraviolet radiation-induced tumor
necrosis factor alpha, which is linked to the development of
cutaneous SCC, modulates differential epidermal microRNAs
expression. Oncotarget. Feb 22–2016.Epub ahead of print. PubMed/NCBI
|
|
90
|
Skourti E, Logotheti S, Kontos CK,
Pavlopoulou A, Dimoragka PT, trougakos IP, gorgoulis V, scorilas A,
Michalopoulos I and Zoumpourlis V: Progression of mouse skin
carcinogenesis is associated with the orchestrated deregulation of
miR-200 family members, miR-205 and their common targets. Mol
Carcinog. Aug 27–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Chen T: The role of MicroRNA in chemical
carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol
Rev. 28:89–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Corsini LR, Bronte G, Terrasi M, Amodeo V,
Fanale D, Fiorentino E, Cicero G, Bazan V and Russo A: The role of
microRNAs in cancer: diagnostic and prognostic biomarkers and
targets of therapies. Expert Opin Ther Targets. 16(Suppl 2):
s103–s109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Pogribny IP, Beland FA and Rusyn I: The
role of microRNAs in the development and progression of
chemical-associated cancers. Toxicol Appl Pharmacol. Nov
24–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Shen J, Abel EL, Riggs PK, Repass J,
Hensley SC, Schroeder LJ, Temple A, Chau A, McClellan SA, Rho O, et
al: Proteomic and pathway analyses reveal a network of inflammatory
genes associated with differences in skin tumor promotion
susceptibility in DBA/2 and C57BL/6 mice. Carcinogenesis.
33:2208–2219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Hemler ME: Tetraspanin functions and
associated micro-domains. Nat Rev Mol Cell Biol. 6:801–811. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Li Q, Yang XH, Xu F, Sharma C, Wang HX,
Knoblich K, Rabinovitz I, Granter SR and Hemler ME: Tetraspanin
CD151 plays a key role in skin squamous cell carcinoma. Oncogene.
32:1772–1783. 2013. View Article : Google Scholar
|
|
97
|
Hara T, Matsumura S, Hakuno F, Takahashi S
and Chida K: PKCα suppresses 7,12-dimethylbenz[a]anthracene-induced
skin tumor formation. Anticancer Res. 32:3097–3101. 2012.PubMed/NCBI
|
|
98
|
Suganuma M, Okabe S, Kurusu M, Iida N,
Ohshima S, Saeki Y, Kishimoto T and Fujiki H: Discrete roles of
cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell
transformation. Int J Oncol. 20:131–136. 2002.
|
|
99
|
Matei C, Tampa M, Ion RM, Georgescu SR,
Dumitrascu GR, Constantin C and Neagu M: Protein microarray for
complex apoptosis monitoring of dysplastic oral keratinocytes in
experimental photodynamic therapy. Biol Res. 47(33)2014. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Tanase CP, Albulescu R and Neagu M:
Application of 3D hydrogel microarrays in molecular diagnostics:
Advantages and limitations. Expert Rev Mol Diagn. 11:461–464. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Kangsamaksin T, Park HJ, Trempus CS and
Morris RJ: A perspective on murine keratinocyte stem cells as
targets of chemically induced skin cancer. Mol Carcinog.
46:579–584. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Trempus CS, Morris RJ, Ehinger M, Elmore
A, Bortner CD, Ito M, Cotsarelis G, Nijhof JG, Peckham J, Flagler
N, et al: CD34 expression by hair follicle stem cells is required
for skin tumor development in mice. Cancer Res. 67:4173–4181. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Klein EA: Can prostate cancer be
prevented? Nat Clin Pract Urol. 2:24–31. 2005. View Article : Google Scholar
|
|
104
|
Sagawa Y, Futakuchi M, Xu J, Fukamachi K,
Sakai Y, Ikarashi Y, Nishimura T, Suzui M, Tsuda H and Morita A:
Lack of promoting effect of titanium dioxide particles on
chemically-induced skin carcinogenesis in rats and mice. J Toxicol
Sci. 37:317–327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Bhatia A, Singh B, Raza K, Shukla A,
Amarji B and Katare OP: Tamoxifen-loaded novel liposomal
formulations: Evaluation of anticancer activity on DMBA-TPA induced
mouse skin carcinogenesis. J Drug Target. 20:544–550. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Enoki T, Tominaga T, Takashima F, Ohnogi
H, Sagawa H and Kato I: Anti-tumor-promoting activities of
agaro-oligosac-charides on two-stage mouse skin carcinogenesis.
Biol Pharm Bull. 35:1145–1149. 2012. View Article : Google Scholar
|
|
107
|
Kowalczyk MC, Spears E, Narog M, Zoltaszek
R, Kowalczyk P, Hanausek M, Yoshimi N, Slaga TJ and Walaszek Z:
Modulation of biomarkers related to tumor initiation and promotion
in mouse skin by a natural β-glucuronidase inhibitor and its
precursors. Oncol Rep. 26:551–556. 2011.PubMed/NCBI
|
|
108
|
Meghea A, Murariu A, Tanase C and Codorean
E: Heavy metals contamination of commercial fish foodstuff -
potential health risks on human consumers. Environ Eng Manag J.
8:233–236. 2009.
|
|
109
|
Kundu JK, Shin YK and Surh YJ: Resveratrol
modulates phorbol ester-induced pro-inflammatory signal
transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as
prime targets. Biochem Pharmacol. 72:1506–1515. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Kleiner HE, Vulimiri SV, Starost MF, Reed
MJ and DiGiovanni J: Oral administration of the citrus coumarin,
isopimpinellin, blocks DNA adduct formation and skin tumor
initiation by 7,12-dimethylbenz[a]anthracene in SENCAR mice.
Carcinogenesis. 23:1667–1675. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Singh RP, Tyagi AK, Zhao J and Agarwal R:
Silymarin inhibits growth and causes regression of established skin
tumors in SENCAR mice via modulation of mitogen-activated protein
kinases and induction of apoptosis. Carcinogenesis. 23:499–510.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Dao V, Pandeswara S, Liu Y, Hurez V, Dodds
S, Callaway D, Liu A, Hasty P, Sharp ZD and Curiel TJ: Prevention
of carcinogen and inflammation-induced dermal cancer by oral
rapamycin includes reducing genetic damage. Cancer Prev Res
(Phila). 8:400–409. 2015. View Article : Google Scholar
|
|
113
|
Pinheiro KS, Ribeiro DR, Alves AV,
Pereira-Filho RN, Oliveira CR, Lima SO, Reis FP, Cardoso JC and
Albuquerque-Júnior RL: Modulatory activity of Brazilian red
propolis on chemically induced dermal carcinogenesis. Acta Cir
Bras. 29:111–117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Manoharan S and Selvan MV: Chemopreventive
potential of geraniol in 7,12-dimethylbenz(a) anthracene (DMBA)
induced skin carcinogenesis in Swiss albino mice. J Environ Biol.
33:255–260. 2012.PubMed/NCBI
|
|
115
|
Sharmila R and Manoharan S: Anti-tumor
activity of rosmarinic acid in 7,12-dimethylbenz(a)anthracene
(DMBA) induced skin carcinogenesis in Swiss albino mice. Indian J
Exp Biol. 50:187–194. 2012.PubMed/NCBI
|
|
116
|
Man'cheva TA, Demidov DV, Plotnikova NA,
Kharitonova TV, Pashkevich IV and Anisimov VN: Melatonin and
metformin inhibit skin carcinogenesis and lipid peroxidation
induced by benz(a)pyrene in female mice. Bull Exp Biol Med.
151:363–365. 2011. View Article : Google Scholar
|
|
117
|
Hu G, Zhang L, Rong Y, Ni X and Sun Y:
Downstream carcinogenesis signaling pathways by green tea
polyphenols: A translational perspective of chemoprevention and
treatment for cancers. Curr Drug Metab. 15:14–22. 2014. View Article : Google Scholar
|
|
118
|
Birt DF, Pinch HJ, Barnett T, Phan A and
Dimitroff K: Inhibition of skin tumor promotion by restriction of
fat and carbohydrate calories in SENCAR mice. Cancer Res. 53:27–31.
1993.PubMed/NCBI
|
|
119
|
Moore T, Beltran L, Carbajal S, Strom S,
Traag J, Hursting SD and DiGiovanni J: Dietary energy balance
modulates signaling through the Akt/mammalian target of rapamycin
pathways in multiple epithelial tissues. Cancer Prev Res (Phila).
1:65–76. 2008. View Article : Google Scholar
|
|
120
|
Stewart JW, Koehler K, Jackson W, Hawley
J, Wang W, Au A, Myers R and Birt DF: Prevention of mouse skin
tumor promotion by dietary energy restriction requires an intact
adrenal gland and glucocorticoid supplementation restores
inhibition. Carcinogenesis. 26:1077–1084. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Katiyar SK: Silymarin and skin cancer
prevention: anti-inflammatory, antioxidant and immunomodulatory
effects (Review). Int J oncol. 26:169–176. 2005.
|
|
122
|
Vaid M and Katiyar SK: Molecular
mechanisms of inhibition of photocarcinogenesis by silymarin, a
phytochemical from milk thistle (Silybum marianum L. Gaertn.)
(Review). Int J Oncol. 36:1053–1060. 2010.PubMed/NCBI
|
|
123
|
Deep G and Agarwal R: Chemopreventive
efficacy of silymarin in skin and prostate cancer. Integr Cancer
Ther. 6:130–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Benjamin CL and Ananthaswamy HN: p53 and
the pathogenesis of skin cancer. Toxicol Appl Pharmacol.
224:241–248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Kiaris H and Spandidos DA: Mutations of
ras genes in human tumors (review). Int J Oncol. 7:413–421.
1995.PubMed/NCBI
|
|
126
|
Hennings H, Spangler EF, Shores R,
Mitchell P, Devor D, Shamsuddin AK, Elgjo KM and Yuspa SH:
Malignant conversion and metastasis of mouse skin tumors: A
comparison of SENCAR and CD-1 mice. Environ Health Perspect.
68:69–74. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Liu J, Mansouri K, Judson RS, Martin MT,
Hong H, Chen M, Xu X, Thomas RS and Shah I: Predicting
hepatotoxicity using ToxCast in vitro bioactivity and chemical
structure. Chem Res Toxicol. 28:738–751. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Bulman A, Neagu M and Constantin C:
Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and
Therapy Monitoring. Curr Proteomics. 10:202–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Spandidos DA: A unified theory for the
development of cancer. Biosci Rep. 6:691–708. 1986. View Article : Google Scholar : PubMed/NCBI
|
